World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: CTRI
Last refreshed on: 24 November 2021
Main ID:  CTRI/2017/06/008908
Date of registration: 23-06-2017
Prospective Registration: Yes
Primary sponsor: Nita Bhandari
Public title: A study on effect of Integrated Nutrition, Health, WASH, Care and Support Interventions during the Pre-pregnancy, Pregnancy and Early Childhood on linear growth of children
Scientific title: Improving Linear Growth of Children in Low Resource Settings through Integrated Nutrition, Health, WASH, Care and Support Interventions during the Pre- and Peri-conceptional Period, Pregnancy and Early Childhood - A Randomized Controlled Trial - Women and Infants Integrated Growth Study (WINGS)
Date of first enrolment: 01-07-2017
Target sample size: 13500
Recruitment status: Closed to Recruitment of Participants
URL:  http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=19339
Study type:  Interventional
Study design:  Randomized Factorial Trial
Method of generating randomization sequence:Stratified block randomization Method of allocation concealment:Centralized Blinding and masking:Open Label
 
Phase:  N/A
Countries of recruitment
India
Contacts
Name: Nita Bhandari   
Address:  45, Kalu Sarai 110016 New Delhi, DELHI India
Telephone: 01146043751
Email: chrd@sas.org.in
Affiliation:  Centre for Health Research and Development, Society for Applied Studies
Name: Nita Bhandari   
Address:  45, Kalu Sarai 110016 New Delhi, DELHI India
Telephone: 01146043751
Email: chrd@sas.org.in
Affiliation:  Centre for Health Research and Development, Society for Applied Studies
Key inclusion & exclusion criteria
Inclusion criteria: Married and living with their husband with no child or 1 child and wish to have more children

Consent to participate

Exclusion criteria: Moving away

Population likely to relocate



Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Intervention(s)
Intervention1: PRE AND PERICONCEPTION - Health: Detect and facilitate treatment of medical conditions known to affect growth of the fetus and young children: As per hospital policy
Screen and treat medical conditions known to affect fetal and infant growth, bi-annual deworming
Intervention2: PRE AND PERICONCEPTION - Health: Birth spacing: Family planning counselling and provision of contraceptives
Intervention3: PRE AND PERICONCEPTION - Nutrition: Adequate micronutrient intake (provide and counsel): Iron folic acid and, multiple micronutrients supplementation
Intervention4: PRE AND PERICONCEPTION - Nutrition: Detect and manage under nutrition: High quality protein and
energy dense snacks
Screen and manage malnutrition and anemia, egg or milk to women with BMI 21 kg/m2

Intervention5: PRE AND PERICONCEPTION - WASH: Promotion of personal and menstrual hygiene: Counselling
Intervention6: PRE AND PERICONCEPTION - Psychosocial support: Promotion of positive thinking and problem-solving skills: Counselling
Promote positive thinking and problem-solving skills, screen and manage depressive symptoms, substance abuse and exposure to second hand smoke
Intervention7: PREGNANCY - Health: Antenatal care: As per WHO recommendations
Minimum 8 antenatal contacts, Screen and treat medical conditions, Tetanus Toxoid immunization, deworming
Intervention8: PREGNANCY - Nutrition: Provision of a protein energy supplement: Provision of High quality protein and energy dense snacks,
Iron folic acid and multiple micronutrients supplementation (Calcium and vitamin D), Weight monitoring and management for low weight gain


Intervention9: PREGNANCY - WASH: Improvement of drinking water quality. Reduce fecal transmission via hand and reduce fecal load in living environment: Provision of water fil
Primary Outcome(s)
Linear growth by 24 months of age - length for age Z-score, proportion stunted



Birth weight, length



Proportion low birth weight



Proportion preterm birth



Proportion small-for gestation ageTimepoint: Linear growth by 24 months of age - length for age Z-score, proportion stunted



Birth (within 1 week)



Birth (within 1 week)



Birth (within 1 week)



Birth (within 1 week)
Secondary Outcome(s)
INTERMEDIATE OUTCOMES: Micronutrient status, anemia status and inflammatory markersTimepoint: 24 months
POSTPARTUM OUTCOMES - Anemia statusTimepoint: 6 months
CHILDREN GROWTH AND DEVELOPMENT: Neurodevelopment scoreTimepoint: 24 months
DISEASE BURDEN OUTCOMES (WOMEN AND CHILDREN): Prevalence of non-communicable diseases, anemia, micronutrient deficiency, malnutrition and infectious diseasesTimepoint: Throughout the study period
BEHAVIOUR OUTCOMES(WOMEN AND CHILDREN): Family planning, substance abuse, WASH behavioursTimepoint: Throughout the study period
CHILDREN GROWTH: Body composition in a subgroupTimepoint: At 1 month
POSTPARTUM OUTCOMES - Severe postpartum morbidityTimepoint: Day 7 of birth
INTERMEDIATE OUTCOMES: Mother infant bonding in a subgroupTimepoint: 6,12 and 18 months
WOMEN: Pregnancy outcomesTimepoint: At end of pregnancy
CHILD GROWTH: Weight and length growth trajectoriesTimepoint: Between birth and 24 mo
CHILDREN GROWTH AND DEVELOPMENT: Caregiver reported developmental outcomesTimepoint: 12 and 24 months
INTERMEDIATE OUTCOMES: Breastfeeding initiation within 1 hour of birthTimepoint: Up to day 7 of birth
INTERMEDIATE OUTCOMES: Exclusively breastfedTimepoint: 1 and 6 months
WOMEN: Anaemia status; Micronutrient status; inflammatory markers; Reproductive tract infectionsTimepoint: Third trimester
WOMEN: BMI of woman; Anaemia status; Micronutrient status; Inflammatory markers; thyroid and diabetes status;

Depression; Reproductive tract infectionsTimepoint: At the time of reporting pregnancy
INTERMEDIATE OUTCOMES: Severe infection in the neonatal period; Prevalence of diarrhea, dysentery, pneumonia, fever in the previous 2 weeks; Prevalence of persistent diarrhea in the previous 4 weeks; Any chronic morbidityTimepoint: 1, 6, 12, 18 and 24 months
POSTPARTUM OUTCOMES: BMITimepoint: 6 and 12 months postpartum
WOMEN: Weight gain during second and third trimesterTimepoint: Second and third trimester
POSTPARTUM OUTCOMES - Inflammatory markersTimepoint: 6 months
CHILDREN GROWTH AND DEVELOPMENT: Body size - Mean length for age Z-score, proportion stunted, mean weight for length Z-score, mean weight for age Z-score, proportion wasted and underweight, mid-upper arm circumference

Timepoint: 6,12, 24 months
INTERMEDIATE OUTCOMES: Complementary feedingTimepoint: 9, 12, 18, 24 months
POSTPARTUM OUTCOMES - Micronutrient statusTimepoint: 6 months
POSTPARTUM OUTCOMES - Postpartum depressionTimepoint: 2 and 12 months
WOMEN: Birth outcomes, stillbirthsTimepoint: End of pregnancy
CHILDREN GROWTH AND DEVELOPMENT: Head circumferenceTimepoint: Day 7, 12, 24 months
INTERMEDIATE OUTCOMES: Continued breastfeedingTimepoint: 12, 18, 24 months
Secondary ID(s)
NIL
Source(s) of Monetary Support
Biotechnology Industry Research Assistance Council (BIRAC) of the Department of Biotechnology, Government of India, 1st Floor ,MTNL Building ,9 , CGO Complex, Lodhi Road, New Delhi-110003 (Next to Scope Complex, Infront of Gate no. 13, JLN Stadium)
Bill & Melinda Gates Foundation, Seattle, USA (supplementary funds approved in September 2018)
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 03/06/2017
Contact:
Society for Applied Studies Ethics Review Committee
Status: Approved
Approval date: 10/01/2019
Contact:
Society for Applied Studies Ethics Review Committee
Status: Approved
Approval date: 22/07/2019
Contact:
Society for Applied Studies Ethics Review Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history